Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • After-Hours Center
  • Earnings
  • Movers
  • News
  • Trading Ideas

Corteva Posts Solid Q4 Earnings, Issues FY 2024 Guidance, Announces $1.0B Repurchase Plan — Stock Rises

By Ryan Gustafson
January 31, 7:00 PM
Corteva Inc. (NYSE: CTVA) shares are trading higher in Wednesday's after-hours session after the company reported its fourth-quarter earnings results.

CTVA

Read More
7 minute read
  • Earnings

Earnings Scheduled For January 31, 2024

By Benzinga Insights
January 31, 7:09 AM
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

ADP

Read More
1 minute read
  • Earnings

Corteva’s Earnings Outlook

By Benzinga Insights
January 30, 10:01 AM
Corteva (NYSE:CTVA) is set to give its latest quarterly earnings report on Wednesday, 2024-01-31. Here’s what investors need…

CTVA

Read More
3 minute read
  • Analyst Ratings

8 Analysts Assess Corteva: What You Need To Know

By Benzinga Insights
January 29, 12:00 PM
In the preceding three months, 8 analysts have released ratings for Corteva (NYSE:CTVA), presenting a wide array of…

CTVA

Read More
3 minute read
  • Analyst Ratings

Analyst Expectations For Corteva’s Future

By Benzinga Insights
January 11, 2:00 PM
Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Corteva (NYSE:CTVA)…

CTVA

Read More
1 minute read
  • Equities
  • General
  • Large Cap
  • Legal
  • Markets
  • Media
  • News

Rising Tide of Lawsuits Over ‘Forever Chemicals’ Reportedly Predicted In 2024, Legal Landscape Altered By $11B Settlements In 2023

By Vandana Singh
December 29, 9:43 AM
In 2023, lawsuits targeting major chemical companies over PFAS contamination in U.S.

CC

Read More
2 minute read
  • Uncategorized

ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US

By Surbhi Jain
December 19, 9:59 AM
With climate change becoming a mega market force, ESG investing is rising. The XVV is up 28% YTD. Agri-Tech stocks like Bayer AG, FMC Corporation, and Corteva Inc are providing climate resilience solutions.

BAYRY

Read More
2 minute read
  • Markets
  • Options

Decoding Corteva’s Options Activity: What’s the Big Picture?

By Benzinga Insights
December 14, 2:16 PM
Deep-pocketed investors have adopted a bullish approach towards Corteva (NYSE:CTVA), and it’s something market players shouldn’t ignore. Our…

CTVA

Read More
2 minute read
  • General
  • Large Cap
  • Legal
  • News

Ohio Resident Challenges Court Ruling Dismissing ‘Forever Chemicals’ Lawsuit Against 3M, Corteva And Others

By Vandana Singh
December 13, 9:26 AM
An Ohio resident, Kevin Hardwick, has urged the full 6th U.S.

CC

Read More
2 minute read
  • Markets
  • News
  • Top Stories
  • Trading Ideas

S&P 500’s Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets

By Piero Cingari
December 7, 2:31 PM
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).

ALB

Posts pagination

Previous 1 2 3 … 10 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service